Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study

被引:1
作者
Bai, Shuheng [1 ]
Chen, Ling [2 ]
Zhu, Guixian [3 ]
Xuan, Wang [1 ]
Hu, Fengyuan [1 ]
Liu, Wanyi [1 ]
Li, Wenyang [1 ]
Lan, Ning [1 ]
Chen, Min [1 ]
Yan, Yanli [1 ]
Li, Rong [1 ]
Yang, Yiping [4 ]
Ren, Juan [1 ]
机构
[1] Xi An Jiao Tong Univ, Dept Radiotherapy, Affiliated Hosp 1, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Chemotherapy, Affiliated Hosp 1, Xian, Peoples R China
[3] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 2, Xian, Peoples R China
[4] Radiotherapy Clin Med Res Ctr Shaanxi Prov, Dept Radiotherapy, Xian, Peoples R China
关键词
colorectal cancer; competing risk analysis; extrahepatic metastasis; prognostic model; SEER; risk factor; COLORECTAL-CANCER; SURVIVAL; CONSENSUS; OUTCOMES; TRENDS; SITE;
D O I
10.3389/fonc.2023.1172670
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionThe occurrence of metastasis is a threat to patients with colon cancer (CC), and the liver is the most common metastasis organ. However, the role of the extrahepatic organs in patients with liver metastasis (LM) has not been distinctly demonstrated. Therefore, this research aimed to explore the prognostic value of extrahepatic metastases (EHMs). MethodsIn this retrospective study, a total of 13,662 colon patients with LM between 2010 and 2015 were selected from the Surveillance, Epidemiology, and End Results database (SEER). Fine and Gray's analysis and K-M survival analysis were utilized to explore the impacts of the number of sites of EHMs and different sites of EHMs on prognosis. Finally, a prognostic nomogram model based on the number of sites of EHMs was constructed, and a string of validation methods was conducted, including concordance index (C-index), receiver operating characteristic curves (ROC), and decision curve analysis (DCA). ResultsPatients without EHMs had better prognoses in cancer-specific survival (CSS) and overall survival (OS) than patients with EHMs (p < 0.001). Varied EHM sites of patients had different characteristics of primary location site, grade, and histology. Cumulative incidence rates for CSS surpassed that for other causes in patients with 0, 1, 2, >= 3 EHMs, and the patients with more numbers of sites of EHMs revealed worse prognosis in CSS (p < 0.001). However, patients with different EHM sites had a minor difference in cumulative incidence rates for CSS (p = 0.106). Finally, a nomogram was constructed to predict the survival probability of patients with EHMs, which is based on the number of sites of EHMs and has been proven an excellent predictive ability. ConclusionThe number of sites of EHMs was a significant prognostic factor of CC patients with LM. However, the sites of EHMs showed limited impact on survival. Furthermore, a nomogram based on the number of sites of EHMs was constructed to predict the OS of patients with EHMs accurately.
引用
收藏
页数:13
相关论文
共 31 条
[1]   Biomarker concordance between primary colorectal cancer and its metastases [J].
Bhullar, D. S. ;
Barriuso, J. ;
Mullamitha, S. ;
Saunders, M. P. ;
O'Dwyer, S. T. ;
Aziz, O. .
EBIOMEDICINE, 2019, 40 :363-374
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   Tailored Systemic Therapy for Colorectal Cancer Liver Metastases [J].
Czauderna, Carolin ;
Luley, Kim ;
von Bubnoff, Nikolas ;
Marquardt, Jens U. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
[4]   Colorectal cancer [J].
Dekker, Evelien ;
Tanis, Pieter J. ;
Vleugels, Jasper L. A. ;
Kasi, Pashtoon M. ;
Wallace, Michael B. .
LANCET, 2019, 394 (10207) :1467-1480
[5]   Development and validation of a prognostic scoring system for patients with colorectal cancer hepato-pulmonary metastasis: a retrospective study [J].
Deng, Shenghe ;
Jiang, Zhenxing ;
Cao, Yinghao ;
Gu, Junnan ;
Mao, Fuwei ;
Xue, Yifan ;
Qin, Le ;
Liu, Ke ;
Wang, Jiliang ;
Wu, Ke ;
Cai, Kailin .
BMC CANCER, 2022, 22 (01)
[6]   Colorectal cancer liver metastases - a population-based study on incidence, management and survival [J].
Engstrand, Jennie ;
Nilsson, Henrik ;
Stromberg, Cecilia ;
Jonas, Eduard ;
Freedman, Jacob .
BMC CANCER, 2018, 18
[7]   MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients [J].
Esfahani, Amir Torshizi ;
Seyedna, Seyed Yoosef ;
Mojarad, Ehsan Nazemalhosseini ;
Majd, Ahmad ;
Aghdaei, Hamid Asadzadeh .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) :13128-13136
[8]   Incidence and prognosis of pulmonary metastasis in colorectal cancer: a population-based study [J].
Ge, Yizhi ;
Lei, Shijun ;
Cai, Bo ;
Gao, Xiang ;
Wang, Guobin ;
Wang, Lin ;
Wang, Zheng .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (02) :223-232
[9]   Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma [J].
Hackl, Christina ;
Neumann, Peter ;
Gerken, Michael ;
Loss, Martin ;
Klinkhammer-Schalke, Monika ;
Schlitt, Hans J. .
BMC CANCER, 2014, 14
[10]   Nomogram of conditional survival probability of long-term Survival for Metastatic Colorectal Cancer: A Real-World Data Retrospective Cohort Study from SEER database [J].
Han, Lingyu ;
Dai, Weixing ;
Mo, Shaobo ;
Xiang, Wenqiang ;
Li, Qingguo ;
Xu, Ye ;
Cai, Guoxiang ;
Wang, Renjie .
INTERNATIONAL JOURNAL OF SURGERY, 2021, 92